Ali Namvar

552 total citations
25 papers, 340 citations indexed

About

Ali Namvar is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Ali Namvar has authored 25 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Epidemiology. Recurrent topics in Ali Namvar's work include vaccines and immunoinformatics approaches (10 papers), Immunotherapy and Immune Responses (9 papers) and Hepatitis B Virus Studies (5 papers). Ali Namvar is often cited by papers focused on vaccines and immunoinformatics approaches (10 papers), Immunotherapy and Immune Responses (9 papers) and Hepatitis B Virus Studies (5 papers). Ali Namvar collaborates with scholars based in Iran and Afghanistan. Ali Namvar's co-authors include Azam Bolhassani, Kimia Kardani, Elnaz Agi, Mohammad Reza Aghasadeghi, Zahra Noormohammadi, Arezoo Asadi, Elahe Taki, Mohsen Heidary, Vahid Khalaj and Esmat Mirabzadeh and has published in prestigious journals such as PLoS ONE, Scientific Reports and Proteins Structure Function and Bioinformatics.

In The Last Decade

Ali Namvar

25 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Namvar Iran 10 236 100 90 77 72 25 340
Phil Bourne United States 2 307 1.3× 193 1.9× 46 0.5× 72 0.9× 125 1.7× 2 395
Xiaohe Lin United States 12 156 0.7× 81 0.8× 144 1.6× 91 1.2× 83 1.2× 15 382
Hugh K. Haddox United States 9 257 1.1× 66 0.7× 89 1.0× 49 0.6× 85 1.2× 19 415
Erica Boni United States 6 254 1.1× 98 1.0× 49 0.5× 59 0.8× 95 1.3× 10 406
Zhenqian Guo China 6 211 0.9× 100 1.0× 61 0.7× 60 0.8× 33 0.5× 6 367
Cindy Sou United States 6 193 0.8× 48 0.5× 105 1.2× 54 0.7× 37 0.5× 8 347
S. Bryson Canada 12 271 1.1× 110 1.1× 57 0.6× 93 1.2× 160 2.2× 15 482
Alex S. Powlesland United Kingdom 9 267 1.1× 284 2.8× 87 1.0× 59 0.8× 88 1.2× 12 507
Stine B. Clemmensen United Kingdom 7 272 1.2× 149 1.5× 42 0.5× 65 0.8× 102 1.4× 9 513
Siu-Kei Chow United States 14 115 0.5× 121 1.2× 194 2.2× 215 2.8× 62 0.9× 16 432

Countries citing papers authored by Ali Namvar

Since Specialization
Citations

This map shows the geographic impact of Ali Namvar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Namvar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Namvar more than expected).

Fields of papers citing papers by Ali Namvar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Namvar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Namvar. The network helps show where Ali Namvar may publish in the future.

Co-authorship network of co-authors of Ali Namvar

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Namvar. A scholar is included among the top collaborators of Ali Namvar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Namvar. Ali Namvar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Namvar, Ali, et al.. (2024). In silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnology Letters. 46(3). 315–354. 2 indexed citations
2.
Namvar, Ali, et al.. (2023). Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections. Molecular Biotechnology. 65(9). 1387–1402. 27 indexed citations
4.
Bolhassani, Azam, et al.. (2022). Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. PLoS ONE. 17(6). e0268251–e0268251. 19 indexed citations
5.
Namvar, Ali, et al.. (2021). Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays. Transfusion and Apheresis Science. 60(5). 103194–103194. 1 indexed citations
7.
Kardani, Kimia, Ali Namvar, Soheila Ajdary, et al.. (2021). In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Biotechnology Letters. 43(8). 1513–1550. 18 indexed citations
8.
Agi, Elnaz, et al.. (2020). Genotyping of intron 1 and 22 inversion of factor VIII gene using IS-PCR in Kurdish patients of Iraq. Eurasian Journal of Biosciences. 14(1). 1181–1185. 1 indexed citations
9.
Kardani, Kimia, Azam Bolhassani, & Ali Namvar. (2020). An overview of in silico vaccine design against different pathogens and cancer. Expert Review of Vaccines. 19(8). 699–726. 48 indexed citations
10.
Namvar, Ali, et al.. (2020). Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools. Biotechnology Letters. 42(3). 403–418. 36 indexed citations
11.
Aghasadeghi, Mohammad Reza, et al.. (2020). Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis. PLoS ONE. 15(10). e0240577–e0240577. 37 indexed citations
12.
Mousavi, Sayed Hamid, et al.. (2019). First Report of Prevalence of Blood-Borne Viruses (HBV, HCV, HIV, HTLV-1 and Parvovirus B19) Among Hemophilia Patients in Afghanistan. Scientific Reports. 9(1). 7259–7259. 7 indexed citations
13.
Namvar, Ali, et al.. (2019). In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine. Scientific Reports. 9(1). 15225–15225. 24 indexed citations
14.
Yousefi, Hossein, et al.. (2019). Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patients. Pediatric Hematology and Oncology. 36(1). 28–39. 6 indexed citations
15.
Ghasemi, Ali, et al.. (2019). Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis C. Journal of Medical Virology. 92(1). 45–52. 5 indexed citations
16.
Karimi‐Sari, Hamidreza, et al.. (2018). Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia. Journal of Medical Virology. 91(3). 419–427. 2 indexed citations
17.
Behnava, Bita, et al.. (2018). Detection of Occult Hepatitis B Virus Among Iranian HCV-Infected Patients with Hemophilia Treated with Direct-Acting Antiviral Agents. Hepatitis Monthly. In Press(In Press). 1 indexed citations
19.
Namvar, Ali, et al.. (2018). Prediction of cross‐clade HIV‐1 T‐cell epitopes using immunoinformatics analysis. Proteins Structure Function and Bioinformatics. 86(12). 1284–1293. 23 indexed citations
20.
Namvar, Ali, Azam Bolhassani, & Mehrdad Hashemi. (2016). HPV16 L2 improves HPV16 L1 gene delivery as an important approach for vaccine design against cervical cancer. Bratislavské lekárske listy/Bratislava medical journal. 116(3). 179–184. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026